In a departure from conventional methods of biological drug discovery, which use mouse antibodies, Epitomics’ unique approach utilizes monoclonal antibodies from rabbits, potentially improving the quality and efficiency
Earlier this year, the company had reported on the favorable pharmacokinetic profile of the drug showing enhanced bioavailability of the Pro-drug PPL-100 (compared to parent drug, PL-100) and
The company will pay a $136 million criminal fine and $567 million to settle civil liabilities. The resolution also ensures that the US Medicaid programs who paid any
The study showed in laboratory models that combination therapy with topotecan and carboplatin is superior to the standard triple-drug therapy using vincristine, carboplatin and etoposide. The new combination
The deal has been approved by the boards of directors of both companies and is expected to close in the fourth quarter of 2005, pending regulatory and other
FASgen’s novel small molecule compounds are designed to limit the appetite and to increase the metabolic breakdown of excess fat stored in the body. Studies in mice reveal
The product formulated utilizing the company’s proprietary TheraPlas delivery technology is composed of interleukin-12 (IL-12) gene expression plasmid and a biocompatible delivery polymer and is designed to increase
AZD-103 is part of a new class of therapeutics that provides significant advantages over the current products on the market which only treat disease symptoms. Strong preclinical data
Risperdal M-Tab is indicated for the treatment of schizophrenia, and the short-term treatment of acute manic or mixed episodes associated with bipolar disorder. The drug is made by
Approximately 25 patients suffering from late-stage head and neck cancer will be recruited for IRX Therapeutics’ phase II trial, involving clinical sites in the US and in Mexico.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.